FDA Inspection 1174733 — Catalent France Beinheim SA
The FDA completed an inspection of Catalent France Beinheim SA on Oct 29, 2020 in Beinheim. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 29, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Beinheim (France)
Additional details
Mutual Recognition Agreement (MRA)